Your browser doesn't support javascript.
loading
GRADE concept paper 2: Concepts for judging certainty on the calibration of prognostic models in a body of validation studies.
Foroutan, Farid; Guyatt, Gordon; Trivella, Marialena; Kreuzberger, Nina; Skoetz, Nicole; Riley, Richard D; Roshanov, Pavel S; Alba, Ana Carolina; Sekercioglu, Nigar; Canelo-Aybar, Carlos; Munn, Zachary; Brignardello-Petersen, Romina; Schünemann, Holger J; Iorio, Alfonso.
Afiliação
  • Foroutan F; Ted Rogers Centre for Heart Research, Peter Munk Cardiac Centre, Toronto, Ontario, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamitlon, Canada. Electronic address: foroutaf@mcmaster.ca.
  • Guyatt G; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamitlon, Canada.
  • Trivella M; Ted Rogers Centre for Heart Research, Peter Munk Cardiac Centre, Toronto, Ontario, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamitlon, Canada; Division of Nephrology, Department of Medicine, London Health Sciences Centre, London, UK; NK: Cochrane Haema
  • Kreuzberger N; NK: Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Skoetz N; NK: Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Evidence-based Oncology, Department I of Internal Medicine, Center for Integrated
  • Riley RD; School of Medicine, Keele University, Keele, United Kingdom.
  • Roshanov PS; Division of Nephrology, Department of Medicine, London Health Sciences Centre, London, UK.
  • Alba AC; Ted Rogers Centre for Heart Research, Peter Munk Cardiac Centre, Toronto, Ontario, Canada.
  • Sekercioglu N; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamitlon, Canada.
  • Canelo-Aybar C; CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; Iberoamerican Cochrane Centre - Department of Clinical Epidemiology and Public Health, Biomedical Research Institute Sant Pau (IIB Sant Pau), Sant Antonio María Claret 167, 08025 Barcelona, Spain.
  • Munn Z; Ted Rogers Centre for Heart Research, Peter Munk Cardiac Centre, Toronto, Ontario, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamitlon, Canada; Division of Nephrology, Department of Medicine, London Health Sciences Centre, London, UK; NK: Cochrane Haema
  • Brignardello-Petersen R; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamitlon, Canada.
  • Schünemann HJ; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamitlon, Canada.
  • Iorio A; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamitlon, Canada.
J Clin Epidemiol ; 143: 202-211, 2022 03.
Article em En | MEDLINE | ID: mdl-34800677
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prognóstico Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prognóstico Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article